01 / Vendor Profile
DMS PHARMACEUTICAL GROUP INC Federal Contracts and Awards
UEI PX72BSBQTKJ3 · CAGE 1UNB0
Federal contract activity attributed to this vendor identity across FY 2020–FY 2026. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2020–FY 2026.
Across FY 2020–FY 2026, FPDS records attribute $1.69B in net contract obligations to DMS PHARMACEUTICAL GROUP INC across 263,422 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
DMS PHARMACEUTICAL GROUP INC contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$190.56M
FY 2026ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2020 | $180.54M | 32,837 | 3 | — |
| FY 2021 | $241.16M | 40,269 | 3 | +33.6% |
| FY 2022 | $261.58M | 42,997 | 1 | +8.5% |
| FY 2023 | $255.62M | 39,001 | 1 | −2.3% |
| FY 2024 | $260.08M | 38,867 | 2 | +1.7% |
| FY 2025 | $299.16M | 40,283 | 1 | +15.0% |
| FY 2026 | $190.56M | 29,168 | 1 | −36.3% |
04 / Federal Customers
Which federal agencies buy from DMS PHARMACEUTICAL GROUP INC?
Ranked by net obligations during FY 2020–FY 2026.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 97AS | $1.69B | 263,394 | 99.8% | |
| 3600 | $2.55M | 26 | 0.2% | |
| 7529 | -$5.3K | 2 | 0.0% |
05 / Contracting Offices
Which contracting offices buy from DMS PHARMACEUTICAL GROUP INC?
Ranked by net obligations during FY 2020–FY 2026.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| SPE2DX | DEFENSE LOGISTICS AGENCY | $898.55M | 133,487 | 53.2% | |
| SPE2DB | DEFENSE LOGISTICS AGENCY | $580.11M | 42,431 | 34.4% | |
| SPE2DR | DEFENSE LOGISTICS AGENCY | $149.16M | 13,459 | 8.8% | |
| SPE2DU | DEFENSE LOGISTICS AGENCY | $27.77M | 2,352 | 1.6% | |
| SPE2DP | DEFENSE LOGISTICS AGENCY | $16.86M | 60,234 | 1.0% | |
| SPE2D3 | DEFENSE LOGISTICS AGENCY | $11.57M | 7,977 | 0.7% | |
| 36C770 | VETERANS AFFAIRS, DEPARTMENT OF | $2.55M | 26 | 0.2% | |
| SPE2D2 | DEFENSE LOGISTICS AGENCY | $686.8K | 2,855 | 0.0% | |
| SPE2D0 | DEFENSE LOGISTICS AGENCY | $152.3K | 455 | 0.0% | |
| 75N900 | NATIONAL INSTITUTES OF HEALTH | -$5.3K | 2 | 0.0% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 424210 | DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS | $1.41B | 137,001 | 2 | 83.4% |
| 325411 | MEDICINAL AND BOTANICAL MANUFACTURING | $261.68M | 70,497 | 1 | 15.5% |
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | $15.72M | 54,045 | 2 | 0.9% |
| 423450 | MEDICAL, DENTAL, AND HOSPITAL EQUIPMENT AND SUPPLIES MERCHANT WHOLESALERS | $1.86M | 1,826 | 1 | 0.1% |
| 325413 | IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING | $1.75M | 11 | 1 | 0.1% |
| 456199 | ALL OTHER HEALTH AND PERSONAL CARE RETAILERS | $27.1K | 20 | 1 | 0.0% |
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | $19.9K | 13 | 1 | 0.0% |
| 446199 | ALL OTHER HEALTH AND PERSONAL CARE STORES | $12.7K | 9 | 1 | 0.0% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
08 / Competition Pattern
How was DMS PHARMACEUTICAL GROUP INC’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for DMS PHARMACEUTICAL GROUP INC?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| SPE2D226F2976 | Jul 8, 2026 | $10 | DEFENSE LOGISTICS AGENCY DLA TROOP SUPPORT | 325411 | 6505 |
10 / Interpreting the Profile
How should you evaluate DMS PHARMACEUTICAL GROUP INC as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.